All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AVENUE THERAPEUTICS, INC.: Last Reported 3/31/2020

Business Address

2 GANSEVOORT STREET
9TH FLOOR
NEW YORK, NY US 10014

Mailing Address

2 GANSEVOORT STREET
9TH FLOOR
NEW YORK, NY US 10014
Phone Number: 781-652-4500 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015
Cash and Cash Equivalents $6,574,000.00 $8,745,000.00 $8,741,000.00 $10,455,000.00 $29,448,000.00 $2,671,000.00 $4,804,000.00 $8,940,000.00 $14,963,000.00 $11,782,000.00 $16,050,000.00 $34,683,000.00 -- $197,000.00 $30,000.00 -- -- $14,000.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $122,000.00 $170,000.00 $76,000.00 $161,000.00 $254,000.00 $152,000.00 $459,000.00 $496,000.00 $310,000.00 $388,000.00 -- -- -- -- -- -- -- --
Total Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Property Plant and Equipement -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $6,696,000.00 $8,915,000.00 $13,878,000.00 $15,677,000.00 $29,763,000.00 $4,525,000.00 $5,263,000.00 $9,436,000.00 $15,273,000.00 $22,170,000.00 $26,176,000.00 $34,705,000.00 $234,000.00 $197,000.00 -- -- -- --
Accounts Payable $217,000.00 $354,000.00 $808,000.00 $851,000.00 $7,259,000.00 $3,089,000.00 $770,000.00 $3,194,000.00 $3,909,000.00 $1,545,000.00 -- -- -- $334,000.00 -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $923,000.00 $2,115,000.00 $1,917,000.00 $1,773,000.00 $9,412,000.00 $5,156,000.00 $2,469,000.00 $4,419,000.00 $5,920,000.00 $2,790,000.00 $1,990,000.00 $7,549,000.00 $9,138,000.00 $8,445,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $75,130,000.00 $74,915,000.00 $74,661,000.00 $74,362,000.00 $73,827,000.00 $41,577,000.00 $41,083,000.00 $40,711,000.00 $40,390,000.00 $38,937,000.00 $38,603,000.00 $38,625,000.00 $159,000.00 $105,000.00 -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-69,359,000.00 $-68,117,000.00 $-62,702,000.00 $-60,460,000.00 $-53,478,000.00 $-42,209,000.00 $-38,290,000.00 $-35,695,000.00 $-31,038,000.00 $-20,661,000.00 $-14,418,000.00 $-11,470,000.00 $-9,064,000.00 $-8,403,000.00 -- -- -- --
Total Stockholders' Equity $5,773,000.00 $6,800,000.00 $11,961,000.00 $13,904,000.00 $20,351,000.00 $-631,000.00 $2,794,000.00 $5,017,000.00 $9,353,000.00 $19,380,000.00 $24,186,000.00 $27,156,000.00 $-8,904,000.00 $-8,248,000.00 -- -- -- $-5,135,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $6,696,000.00 $8,915,000.00 $13,878,000.00 $15,677,000.00 $29,763,000.00 $4,525,000.00 $5,263,000.00 $9,436,000.00 $15,273,000.00 $22,170,000.00 $26,176,000.00 $34,705,000.00 $234,000.00 $197,000.00 -- -- -- --

Statement of Operations

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $697,000.00 $22,194,000.00 $1,706,000.00 $16,633,000.00 $10,241,000.00 $17,696,000.00 $14,981,000.00 $3,754,000.00 $9,439,000.00 $6,698,000.00 $2,000,000.00 $580,000.00 $133,000.00 $1,331,000.00 $1,168,000.00 $421,000.00 $564,000.00 $961,000.00
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- -- $6,325,000.00 $2,848,000.00 $1,744,000.00 $504,000.00 $516,000.00 $383,000.00 $638,000.00 $840,000.00 --
Loss from Operations $-1,274,000.00 $-26,265,000.00 $-2,323,000.00 $-18,468,000.00 $-11,360,000.00 $-21,816,000.00 $-17,714,000.00 $-4,681,000.00 $-10,425,000.00 $-11,421,000.00 $-5,096,000.00 $-1,744,000.00 $-504,000.00 $-2,377,000.00 $-383,000.00 $-1,478,000.00 $-840,000.00 $-4,843,000.00
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 -- -- -- --
Common Stock Shares Outstanding 16,682,803 16,682,190 16,661,355 16,559,747 16,557,122 10,667,714 10,662,398 10,554,170 10,552,045 10,265,083 10,265,174 10,041,008 10,024,405 9,773,810 -- -- -- --
Copyright 2020 PursePoor.com